M3 Wake Research, Inc - M3 WR - ERN - PPDS

Raleigh, North Carolina 27612

0 studies enrolling now · 2 studies all time

What they study most

Cytomegalovirus Infection, Respiratory Syncytial Virus

Studies at this site

• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age — Completed
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early